Intact aggrecan and chondroitin sulfate-depleted aggrecan core glycoprotein inhibit axon growth in the adult rat spinal cord

Experimental Neurology

Volumn 184, Issue 2, 2003, Pages 981-990

  Lemons, Michele L ^a,b,c   Sandy, John D ^d   Anderson, Douglas K ^a,b,c   Howland, Dena R ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Aggrecan; Chondroitin sulfate glycosaminoglycan; Chondroitin sulfate proteoglycan; Chondroitinase ABC; Core protein; Dorsal root ganglia; Glycoprotein; Hyalectan; Lectican; Regeneration; Spinal cord injury

Indexed keywords

AGGRECAN; CHONDROITIN SULFATE; GLYCOPROTEIN; KERATAN SULFATE; MATRIGEL; PROTEOGLYCAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASSAY; AXONAL INJURY; CARTILAGE; CELL CULTURE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DORSAL ROOT; MAMMAL; MODEL; NERVE FIBER GROWTH; NEURITE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; SPINAL CORD HEMISECTION;

EID: 0742280685     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00383-2     Document Type: Article

References (53)

1. Bandtlow C.E., Zimmermann D.R. Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol. Rev. 80:2000;1267-1290.
2. Bovolenta P., Fernaud-Espinosa I. Nervous system proteoglycans as modulators of neurite outgrowth. Prog. Neurobiol. 61:2000;113-132.
3. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature. 416:2002;636-640.
4. Burg M.A., Cole G.J. Claustrin, an antiadhesive neural keratan sulfate proteoglycan, is structurally related to MAP1B. J. Neurobiol. 25:1994;1-22.
5. Calabro A., Hascall V.C., Midura R.J. Adaptation of FACE methodology for microanalysis of total hyaluronan and chondroitin sulfate composition from cartilage. Glycobiology. 10:2000;283-293.
6. Chung K.Y., Taylor J.S., Shum D.K., Chan S.O. Axon routing at the optic chiasm after enzymatic removal of chondroitin sulfate in mouse embryos. Development. 127:2000;2673-2683.
7. Cole G.J., McCabe C.F. Identification of a developmentally regulated keratan sulfate proteoglycan that inhibits cell adhesion and neurite outgrowth. Neuron. 7:1991;1007-1018.
8. Condic M.L., Lemons M.L. Extracellular matrix in spinal cord regeneration: getting beyond attraction and inhibition. NeuroReport. 13:2002;A37-A48.
9. Condic M.L., Snow D.M., Letourneau P.C. Embryonic neurons adapt to the inhibitory proteoglycan aggrecan by increasing integrin expression. J. Neurosci. 19:1999;10036-10043.
10. Couchman J.R., Caterson B., Christner J.E., Baker J.R. Mapping by monoclonal antibody detection of glycosaminoglycans in connective tissues. Nature. 307:1984;650-652.
11. Davies S.J., Fitch M.T., Memberg S.P., Hall A.K., Raisman G., Silver J. Regeneration of adult axons in white matter tracts of the central nervous system. Nature. 390:1997;680-683.
12. Delehedde M., Lyon M., Gallagher J.T., Rudland P.S., Fernig D.G. Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts. Biochem. J. 366:2002;235-244.
13. Doege K., Sasaki M., Horigan E., Hassell J.R., Yamada Y.J. Complete primary structure of the rat cartilage proteoglycan core protein deduced from cDNA clones. J. Biol. Chem. 262:1987;17757-17767.
14. Dou C.L., Levine J.M. Inhibition of neurite growth by the NG2 chondroitin sulfate proteoglycan. J. Neurosci. 14:1994;7616-7628.
15. Dou C.L., Levine J.M. Identification of a neuronal cell surface receptor for a growth inhibitory chondroitin sulfate proteoglycan (NG2). J. Neurochem. 68:1997;1021-1030.
16. Fitch M.T., Silver J. Activated macrophages and the blood-brain barrier: inflammation after CNS injury leads to increases in putative inhibitory molecules. Exp. Neurol. 148:1997;587-603.
17. Gates M.A., Fillmore H., Steindler D.A. Chondroitin sulfate proteoglycan and tenascin in the wounded adult mouse neostriatum in vitro: dopamine neuron attachment and process outgrowth. J. Neurosci. 16:1996;8005-8018.
18. Gates M.A., Laywell E.D., Fillmore H., Steindler D.A. Astrocytes and extracellular matrix following intracerebral transplantation of embryonic ventral mesencephalon or lateral ganglionic eminence. Neuroscience. 74:1996;579-597.
19. Inatani M., Honjo M., Otori Y., Oohira A., Kido N., Tano Y., Honda Y., Tanihara H. Inhibitory effects of neurocan and phosphacan on neurite outgrowth from retinal ganglion cells in culture. Invest. Ophthalmol. Vis. Sci. 42:2001;1930-1938.
20. Kinoshita A., Yamada S., Haslam S.M., Morris H.R., Dell A., Sugahara K. Isolation and structural determination of novel sulfated hexasaccharides from squid cartilage chondroitin sulfate E that exhibits neuroregulatory activities. Biochemistry. 40:2001;12654-12665.
21. Kleinman H.K., McGarvey M.L., Hassell J.R., Star V.L., Cannon F.B., Laurie G.W., Martin G.R. Basement membrane complexes with biological activity. Biochemistry. 25:1986;312-318.
22. Lemons M.L., Howland D.R., Anderson D.K. Chondroitin sulfate proteoglycan immunoreactivity increases following spinal cord injury and transplantation. Exp. Neurol. 160:1999;51-65.
23. Lemons M.L., Sandy J.D., Anderson D.K., Howland D.R. Intact aggrecan and fragments generated by both aggrecans and metalloproteinase-like activities are present in the developing and adult rat spinal cord and their relative abundance is altered by injury. J. Neurosci. 21:2001;4772-4781.
24. Lohmander L.S., De Luca S., Nilsson B., Hascall V.C., Caputo C.B., Kimura J.H., Heinegard D. Oligosaccharides on proteoglycans from the swarm rat chondrosarcoma. J. Biol. Chem. 255:1980;6084-6091.
25. Madison R., da Silva C.F., Dikkes P., Chiu T.H., Sidman R.L. Increased rate of peripheral nerve regeneration using bioresorbable nerve guides and a laminin-containing gel. Exp. Neurol. 88:1985;767-772.
26. Margolis R.U., Margolis R.K. Chondroitin sulfate proteoglycans as mediators of axon growth and pathfinding. Cell Tissue Res. 290:1997;343-348.
27. McKeon R.J., Schreiber R.C., Rudge J.S., Silver J. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J. Neurosci. 11:1991;3398-3411.
28. McKeon R.J., Hoke A., Silver J. Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp. Neurol. 136:1995;32-43.
29. Milev P., Maurel P., Chiba A., Mevissen M., Popp S., Yamaguchi Y., Margolis R.K., Margolis R.U. Differential regulation of expression of hyaluronan-binding proteoglycans in developing brain: aggrecan, versican, neurocan, and brevican. Biochem. Biophys. Res. Commun. 247:1998;207-212.
30. Moon L.D., Asherm R.A., Rhodes K.E., Fawcett J.W. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat. Neurosci. 4:2001;465-466.
31. Moon L.D., Asher R.A., Fawcett J.W. Limited growth of severed CNS axons after treatment of adult rat brain with hyaluronidase. J. Neurosci. Res. 71:2003;23-37.
32. Oakley R.A., Tosney K.W. Peanut agglutinin and chondroitin-6-sulfate are molecular markers for tissues that act as barriers to axon advance in the avian embryo. Dev. Biol. 147:1991;187-206.
33. Oegema T.R. Jr., Kraft E.L., Jourdian G.W., VanValen T.R. Phosphorylation of chondroitin sulfate in proteoglycans from the swarm rat chondrosarcoma. J. Biol. Chem. 259:1984;1720-1726.
34. Pindzola R.R., Doller C., Silver J. Putative inhibitory extracellular matrix molecules at the dorsal root entry zone of the spinal cord during development and after root and sciatic nerve lesions. Dev. Biol. 156:1993;34-48.
35. Ramon y Cajal S. Cajal's Degeneration and Regeneration of the Nervous System. 1991;Oxford Univ. Press, New York.
36. Sandy J.D., Flannery C.R., Neame P.J., Lohmander L.S. The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. J. Clin. Invest. 89:1992;1512-1516.
37. Sandy J.D., Thompson V., Doege K., Verscharen C. The intermediates of aggrecanase-dependent cleavage of aggrecan in rat chondrosarcoma cells treated with interleukin-1. Biochem. J. 351:2000;161-166.
38. Schmalfeldt M., Bandtlow C.E., Dours-Zimmermann M.T., Winterhalter K.H., Zimmermann D.R. Brain derived versican V2 is a potent inhibitor of axonal growth. J. Cell Sci. 113:2000;807-816.
39. Schwartz M.A., Shattil S.J. Signaling networks linking integrins and rho family GTPases. Trends Biochem. Sci. 25:2000;388-391.
40. Schwartz N.B., Hennig A.K., Krueger R.C. Jr., Krzystolik M., Li H., Mangoura D. Developmental expression of S103L cross-reacting proteoglycans in embryonic chick. Prog. Clin. Biol. 1993;505-514.
41. Schwartz N.B., Domowicz M., Krueger R.C. Jr., Li H., Mangoura D. Brain aggrecan. Perspect. Dev. Neurobiol. 3:1996;291-306.
42. Schwartz N.B., Pirok E.W. III, Mensch J.R. Jr., Domowicz M.S. Domain organization, genomic structure, evolution, and regulation of expression of the aggrecan gene family. Prog. Nucleic Acid Res. Mol. Biol. 62:1999;177-225.
43. Snow D.M., Letourneau P.C. Neurite outgrowth on a step gradient of chondroitin sulfate proteoglycan (CS-PG). J. Neurobiol. 23:1992;322-336.
44. Snow D.M., Lemmon V., Carrino D.A., Caplan A.I., Silver J. Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro. Exp. Neurol. 109:1990;111-130.
45. Snow D.M., Watanabe M., Letourneau P.C., Silver J. A chondroitin sulfate proteoglycan may influence the direction of retinal ganglion cell outgrowth. Development. 113:1991;1473-1485.
46. Snow D.M., Brown E.M., Letourneau P.C. Growth cone behavior in the presence of soluble chondroitin sulfate proteoglycan (CSPG), compared to behavior on CSPG bound to laminin or fibronectin. Int. J. Dev. Neurosci. 14:1996;331-349.
47. Snow D.M., Mullins N., Hynds D.L. Nervous system-derived chondroitin sulfate proteoglycans regulate growth cone morphology and inhibit neurite outgrowth: a light, epifluorescence, and electron microscopy study. Microsc. Res. Tech. 54:2001;273-286.
48. Ughrin Y.M., Chen Z.J., Levine J.M. Multiple regions of the NG2 proteoglycan inhibit neurite growth and induce growth cone collapse. J. Neurosci. 23:2003;175-186.
49. Yamagata T., Saito H., Habuchi O., Suzuki S. Purification and properties of bacterial chondroitinases and chondrosulfatases. J. Biol. Chem. 243:1968;1523-1535.
50. Yamaguchi Y. Lecticans: organizers of the brain extracellular matrix. Cell Mol. Life Sci. 57:2000;276-289.
51. Yick L.W., Wu W., So K.F., Yip H.K., Shum D.K. Chondroitinase ABC promotes axonal regeneration of Clarke's neurons after spinal cord injury. NeuroReport. 11:2000;1063-1067.
52. Yu X., Bellamkonda R.V. Dorsal root ganglia neurite extension is inhibited by mechanical and chondroitin sulfate-rich interfaces. J. Neurosci. Res. 66:2001;303-310.
53. Zuo J., Neubauer D., Dyess K., Ferguson T.A., Muir D. Degradation of chondroitin sulfate proteoglycan enhances the neurite- promoting potential of spinal cord tissue. Exp. Neurol. 154:1998;654-662.